Endometriosis and Subfertility - What to do?

Sujoy Dasgupta
Sujoy DasguptaConsultant Obstetrician, Gynaecologist, Infertility Specialist em Genome fertility Centre, Kolkata
Dr Sujoy Dasgupta
MBBS (Gold Medalist, Hons)
MS (OBGY- Gold Medalist)
DNB (New Delhi)
MRCOG (London)
Advanced ART Course for Clinicians (NUHS, Singapore)
M Sc, Sexual and Reproductive Medicine (South Wales, UK)
Clinical Director, Genome Fertility Centre, Kolkata
Managing Committee Member, BOGS, 2023-24
Executive Committee Member, ISAR Bengal, 2022-24
Clinical Examiner, MRCOG Part 3 Examination
Winner, Prof Geoffrey Chamberlain Award, RCOG World Congress,
London, 2019
Endometriosis and subfertility…..
what to do?
• A chronic, estrogen-
dependent, inflammatory,
painful disorder in which
endometrial tissue grows
outside the uterus.
• Known for recurrence
• No single treatment is ideal
for all patients, management
chosen should be directed to
individual needs of each
patient
• Combination therapy may
be ideal
• Couple’s problem
• About 1/3rd of women
with endometriosis also
suffer from subfertility.
• Endometriosis does not
equal infertility. It just
implies that some women
may have a harder time
becoming pregnant.
• Once the endometriosis is
treated then women often
conceive naturally without
any ART
Endometriosis Subfertility
Endometriosis and subfertility
• Dysparaeunia
• Distorted Pelvic Anatomy
• Altered Peritoneal Function
• Abnormal Uterotubal Transport
• Hormonal and Ovulatory Abnormalities.
• Impaired Implantation
• Oocyte and Embryo Quality
Endometriosis and Subfertility - What to do?
Endometriosis-subfertility:
Basic principles of management
• Medical management is not possible
• Medical management does NOT improve the
chance of conception
• Laparoscopy confirms diagnosis and the severity
• Laparoscopy improves pain
• Laparoscopy improves chance of natural
conception
• Laparoscopy does NOT improve the success of
IVF
Case Scenario 1
• Mrs AC, 33 yr, trying
for pregnancy for 2
years
• c/o severe and
progressively
increasing
dysmenorrhoea and
dysparaeunia
• TVS-
Line of management?
• Laparoscopy
• Fertility preservation then consider laparoscopy
• IVF only
• Hormonal therapy for 3 months, then reevaluate
Factors to decide the mode of
treatment?
Mrs AC
Ovarian reserve- Age, AMH,
AFC
Age 33, AMH- 2.5 ng/ml, AFC-
8+10
Semen parameters Normozoospermia
Tubal patency Tubes not yet checked
Severity of symptoms Severe pain not responded to
NSAID
Past surgery No previous surgery
Previous fertility treatment Received 6 cycles of letrozole
for OI
Patient’s wishes Relief of pain and wants to
conceive
Medical therapy
Hormonal therapies
• Clinicians should NOT
prescribe ovarian
suppression treatment to
improve fertility
• Most of the hormone
therapies will prevent
pregnancy
• Ovarian suppression does
NOT improve subsequent
ovarian response (ESHRE,
2022)
Analgesics
• NSAIDs should be avoided
around the time of ovulation
Surgery for Endometriosis-Subfertility
rASRM stage
I/II
Improves the rate of ongoing pregnancy.
Both ablation and excision (CO2 laser vaporization
> monopolar electrocoagulation)
Endometrioma May increase their chance of natural pregnancy
Cystectomy >> Drainage/coagulation
Deep
endometriosis
 For infertility, severe pain, bowel stenosis
radical excision combined with bowel segmental
resection and anastomosis →improves spontaneous
pregnancy rate
• Operative lap > diagnostic lap
• Still controversial if cumulative pregnancy rate is more after surgery but
time to achieve pregnancy was significantly shorter
• No compelling data from comparative studies exist
(RCOG, 2017; NICE, 2017; ESHRE, 2022)
Surgery for Endometriosis-Subfertility
rASRM stage
I/II
Improves the rate of ongoing pregnancy.
Both ablation and excision (CO2 laser vaporization
> monopolar electrocoagulation)
Endometrioma May increase their chance of natural pregnancy
Cystectomy >> Drainage/coagulation
Deep
endometriosis
 For infertility, severe pain, bowel stenosis
radical excision combined with bowel segmental
resection and anastomosis →improves spontaneous
pregnancy rate
• Operative lap > diagnostic lap
• Still controversial if cumulative pregnancy rate is more after surgery but
time to achieve pregnancy was significantly shorter
• No compelling data from comparative studies exist
(RCOG, 2017; NICE, 2017; ESHRE, 2022)
Surgery for Endometriosis-Subfertility
rASRM stage
I/II
Improves the rate of ongoing pregnancy.
Both ablation and excision (CO2 laser vaporization
> monopolar electrocoagulation)
Endometrioma May increase their chance of natural pregnancy
Cystectomy >> Drainage/coagulation
Deep
endometriosis
 For infertility, severe pain, bowel stenosis
radical excision combined with bowel segmental
resection and anastomosis →improves spontaneous
pregnancy rate
• Operative lap > diagnostic lap
• Still controversial if cumulative pregnancy rate is more after surgery but
time to achieve pregnancy was significantly shorter
• No compelling data from comparative studies exist
(RCOG, 2017; NICE, 2017; ESHRE, 2022)
1. 3-10% chances of damaging the
surrounding organs- bladder,
bowel, ureter, nerves
2. Possible decline in ovarian
reserve
3. Risk of oophorectomy
4. Complete excision of
endometriotic tissue not possible.
5. May NOT reverse the
inflammatory and biomolecular
changes shown to influence
fertilisation and implantation.
6. Needs skill
Vercellini et al., 2009; Lebovic, 2016
Mrs AC underwent laparoscopy
• Right Ovarian 5 cm
chocolate cyst
removed
• Severe adhesion in
POD- complete
adhesiolysis was
done
• Dye test B/L positive
After laparoscopy- Attempt of
natural conception or IVF?
• Women should be counselled of their chances of
becoming pregnant after surgery.
• To identify patients that may benefit from ART after
surgery, the Endometriosis Fertility Index (EFI)
should be used as it is validated, reproducible and
cost-effective.
• The results of other fertility investigations such as
their partner’s sperm analysis should be taken into
account (ESHRE, 2022)
Endometriosis and Subfertility - What to do?
Adamson and Pasta. Fertil Steril. 2010
What should be the post-operative
treatment plan?
• Counselling
• Ovarian
suppression after
surgery?
 Chance of recurrence
 After surgery- conception
chance is high
 Women seeking pregnancy
should NOT be prescribed
postoperative hormone
suppression with the sole
purpose to enhance future
pregnancy rates (ESHRE, 2022)
Mrs AC is now pain-free
• Visited 4 doctors over the period of next 2
years.
• Received different brands of letrozole for
ovulation induction- total 12 cycles
• She wants to do IUI
ESHRE, 2022
rASRM stage I/II
endometriosis
•May perform IUI with ovarian
stimulation, instead of expectant
management or IUI alone
•IUI+OS increases pregnancy rates.
(better than expectant management or
IUI alone)
rASRM stage III/IV
endometriosis
•The value of IUI in women with tubal
patency is uncertain
•IUI +OS could be considered
Can IUI be done in endometriosis?
ESHRE, 2022
rASRM stage I/II
endometriosis
•May perform IUI with ovarian
stimulation, instead of expectant
management or IUI alone
•IUI+OS increases pregnancy rates.
(better than expectant management or
IUI alone)
rASRM stage III/IV
endometriosis
•The value of IUI in women with tubal
patency is uncertain
•IUI +OS could be considered
Can IUI be done in endometriosis?
Hughes, 1997 Meta-analysis- IUI success is halved in stage I/II
endometriosis
Gandhi et al., 2014 No difference between expectant management and
IUI
Dmowski et al., 2002 First-cycle chance of pregnancy with IVF is
significantly higher than the cumulative
pregnancy rate after 6 IUI cycles
Van der Houwen et al., 2014;
D’Hooghe et al., 2006
The risk of endometriosis recurrence appears to
be increased by IUI (more than IVF)
IVF, but not IUI, can be expected to overcome the
detrimental effects of a pelvic inflammatory
milieu.
Limitations of IUI in endometriosis
Endometriosis Treatment Italian Club, 2019
Case Scenario 2
• Mrs FR, 32 yr, has been trying for pregnancy
for last 2 years. AMH, AFC, HSG all
normal.
• Husband is having azoospermia. Donor sperm
is no acceptable.
• B/L endometrioma (6 cm in right side, 4 cm
left side)
• Minimum dysmenorrhoea
25
Options for Mrs FR
1. TESA-ICSI directly?
2. Laparoscopy before
IVF-ICSI?
 Severity of pain
 Scan finding-
1. Cyst location
2. AFC
3. Accessibility of the follicles
4. Hydrosalpinx
Surgery prior to IVF
• Progressive decline in ovarian reserve
• Higher gonadotrophin consumption
• Lower number of oocyte retrieved
Raffi et al., 2012; Somigliana et al., 2012; Sugita et al., 2013; Hamdan et
al., 2015; Polyzos and Sunkara, 2015; Brink Laursen et al., 2017; Tao
et al., 2017; Nickkho-Amiry et al., 2018
Operative Lap does NOT improve IVF
outcome
In infertile women with
endometrioma > 3 cm only
consider cystectomy prior to
ART to improve
1. endometriosis-associated
pain or
2. the accessibility of
follicles (ESHRE, 2022)
Concern about
endometrioma puncture
during OPU?
• In women with
endometrioma, clinicians
may use antibiotic
prophylaxis at the time of
oocyte retrieval, although
the risk of ovarian abscess
following follicle
aspiration is low (0-1.9%)
(ESHRE, 2022, RCOG 2017)
Complications during and after OPU
• Technical difficulties during oocyte retrieval is low,
• No data to suggest that surgery will prevent adhesion reformation
and facilitate oocyte retrieval effectively.
• Risks of infection from an endometrioma (0–1.9%)
• Follicular fluid contamination (2.8–6.1%)
• Progression of pelvic endometriosis???
• Women with endometriosis can be reassured regarding the safety of
ART since the recurrence rates are not increased compared to
those women not undergoing ART.
ESHRE, 2022; Koch et al., 2012; RCOG, 2017
Ultrasound-guided Aspiration
• Transvaginal USG-guided drainage
without surgery does not seem to be
effective.
• a high recurrence rate
• To decrease recurrence rate, aspiration is
combined with in situ injection of
tetracycline/ethanol/methotrexate
• Disadvantages:
 Complications: infection, abscess
formation, and pain
 inability to rule out any malignancy
 risk of pelvic adhesion
31
RCOG Scientific Impact Paper (2017)
Directly ART
• Asymptomatic women,
• women of advanced
reproductive age,
• those with reduced ovarian
reserve,
• B/L endometriomas,
• a history of prior ovarian
surgery
Surgery before IVF
• Highly symptomatic women,
• with an intact ovarian reserve,
• unilateral and large cysts,
• cysts with suspicious
radiological and clinical
features (The lifetime
probability of Ca ovary 1-2%)
32
IVF protocol for Endometriosis
• Any specific IVF
stimulation protocol?
• Pretreatment COC/
Progesterone?
• No specific protocol can be
recommended.
• Both GnRH antagonist and agonist
protocols can be offered based on
patients’ and physicians’ preferences
as no difference in pregnancy or
live birth rate has been
demonstrated
• Insufficient evidence to recommend
prolonged administration of the
COC/progestogens as a pre-treatment
to ART to increase live birth rates
(ESHRE, 2022)
Down regulation with GnRH agonist depot?
• The administration of GnRH agonists for a period of
3-6 months prior to IVF or ICSI in women with
endometriosis increases the odds of clinical
pregnancy by 4-fold.
Georgiou EX, Melo P, Baker PE, Sallam HN, Arici A, Garcia‐Velasco JA,
Abou‐Setta AM, Becker C, Granne IE. Long‐term GnRH agonist therapy before in
vitro fertilisation (IVF) for improving fertility outcomes in women with endometriosis.
Cochrane Database of Systematic Reviews 2019, Issue 11. Art. No.: CD013240.
DOI: 10.1002/14651858.CD013240.pub2
• In light of the paucity and very low quality of
existing data, particularly for the primary
outcomes examined, further high‐quality trials
are required to definitively determine the impact
of long‐term GnRH agonist therapy on IVF/ICSI
outcomes, not only compared to no pretreatment,
but also compared to other proposed alternatives
to endometriosis management
Paradigm Shift?
ESHRE, 2013 ESHRE, 2022
• Clinicians can prescribe
GnRH agonists for a period
of 3 to 6 months prior to
treatment with ART to
improve clinical pregnancy
rates in infertile women
with endometriosis
• The extended administration
of GnRH agonist prior to
ART treatment to improve
live birth rate in infertile
women with endometriosis
(ultralong protocol) is no
longer recommended due
to unclear benefits.
Muller V, Kogan I, Yarmolinskaya M, Niauri D, Gzgzyan A, Aylamazyan E.
(2017). Dienogest treatment after ovarian endometrioma removal in infertile
women prior to IVF, Gynecological Endocrinology, 33:sup1, 18-21,
Tamura, H., Yoshida, H., Kikuchi, H. et al. The clinical outcome of Dienogest treatment
followed by in vitro fertilization and embryo transfer in infertile women with
endometriosis. J Ovarian Res 12, 123 (2019).
• No significant difference in the implantation and
miscarriage rates between the groups
• The cumulative pregnancy rate and live birth rate were
lower in the DNG group than in the control group.
Case Scenario 3
• Mrs PC, 34 yr, trying for pregnancy for 1
year.
• All investigations (Semen, AMH, HSG)
normal.
• 2 cm endometrioma in left ovary.
• No pain.
Conservative management for spontaneous
conception
Encourage to try natural conception before seeking fertility treatment-
1. Young women,
2. regular menstrual cycles and
3. an incidental finding of an ovarian endometrioma
4. without suspicion of malignancy
•43% spontaneous pregnancy rate during the 6-month follow up period
•Similar ovulation rates in the affected ovary to the healthy ovary
Benaglia et al., 2009; Leone Roberti Maggiore et al., 2015; RCOG, 2017
40
ESHRE, 2022
Case Scenario 4
• Mrs MS, 28 yr, trying for pregnancy for 3 years.
She had severe dysmenorrhoea, dyschezia and
dysuria.
• There was 5 cm unilateral endometrioma and
MRI scan suggested the possibility of
rectosigmoid endometriosis.
• AMH 2.3 ng/ml, tubes not checked, husband’s
semen normal.
• She wanted to defer surgery for 4 months
because of professional commitments
Preoperative hormonal therapies
NICE, 2017
•Consider GnRH agonist x 3
cycles before surgery for deep
infiltrating endometriosis
ESHRE, 2022
•In clinical practice, surgeons prescribe
preoperative medical treatment with
GnRH agonists as this can facilitate
surgery due to reduced inflammation,
vascularisation of endometriosis lesions
and adhesions
•No controlled studies supporting this
•Should be offered before surgery to
women with painful symptoms in the
waiting period before the surgery can
be performed, with the purpose of
reducing pain before, not after, surgery.
Mrs MS underwent Laparoscopy
• Grade IV endometriosis
• Tubes and ovaries difficult to identify
• Tubal patency- Right- slow spill, Left- no spill
• Adhesiolysis could not be done
44
Next step
• GnRH Agonist/ Dineogest post-op
• IVF
• Re-operation by expert
45
Complete excision group
vs
incomplete excision
• significantly higher
complication rate (9.1% VS
0%, P<0.001)
• significant decrease in pain
(VAS score 5.6±3.9 VS
2.9±3.3, P=0.001)
• significantly lower
postoperative recurrence rate
(3.9% VS 35.3%, P=0.000)
• similar pregnancy rate
Complete excision
vs
incomplete excision + post-
operative GnRH agonist
• similar pain score (5.6±3.9
VS 4.5±3.2, P=0.272).
• significantly lower recurrence
rate (3.9% VS 29.4%,
P=0.000).
How does endometriosis affect
oocytes and embryos?
• Ooplasm- “dark cytoplasm,"
"and "diffused cytoplasmic
granularity.“ (Rienzi et al.,
2011).
• Oocytes with degenerative
signs (Ayse et al., 2014).
• Altered oocyte morphology,
abnormal mitochondrial
content (Sanchez et al., 2017).
• Altered follicular fluid
molecules (VEGF, IL-6)
(Garrido et al., 2000).
Does endometriosis affect IVF
success?
• Systematic review- stage I and II endometriosis, the
pregnancy rate was similar to that in tubal infertility,
although in stage III and IV endometriosis, the
pregnancy rate was significantly poor (Barnhart, et al.,
2012).
• ESHRE database- No difference in IVF outcome
between endometriosis and other fertility issues
(Dunselman et al., 2014).
• Recent Meta-analysis- Endometriosis does NOT
affect embryo quality or IVF outcome (Dongye et al., 2021.
Qu et al., 2022).
Ms MS had IVF-Failure
Role of laparoscopy?
• Normal HSG, repeated IVF failure- 57% cases can have
endometriosis- surgical treatment improves outcome (Yu et
al., 2019)
• In symptomatic women with severe endometriosis-
surgery improves IVF outcome (Soriano et al., 2016)
• Need to do 40 laparoscopy to achieve a pregnancy (ASRM,
2012)
• Down-regulation with GnRH agonist and letrozole may be
useful in RIF patients without surgically proved
endometriosis (Moustafa and Young, 2020)
Case Scenario 5
• Mrs JK, 37 years trying
for pregnancy for 4 years
• Tried multiple cycles of
OI with letrozole and CC
• HSG, AMH, Semen all
normal
• No dysmenorrhoea
• “Unexplained
Subfertility”
• Role of laparoscopy to
diagnose endometriosis
and treatment?
50
Unexplained Infertility
• Reflects an incomplete fertility evaluation
• 20-40% cases of unexplained infertility may be
because of undiagnosed endometriosis
Hurt, 2003; Fadhlaoui et al., 2014
Endometriosis and Subfertility - What to do?
Recent Studies on Endometriosis and
Unexplained Infertility
 RMeta-Analysis
• Success rate of IVF - ∼25% (NNT- 4)
European IVF-Monitoring Consortium (EIM) for ESHRE, 2016
Jacobson et al., 2010 Duffy et al., 2014
OR for ongoing pregnancy (95% CI) 1.64 (1.05– 2.57) 1.94 (1.20–3.16)
The number of infertile women that should
undergo destruction of superficial peritoneal
endometriosis
12 8
The prevalence of grade I/ II endometriosis among
women with unexplained infertility
≤50%
NNT 24 16
Laparoscopy to diagnose asymptomatic DIE?
• Uncommon to be asymptomatic
• Uncomplicated- If no symptoms of ureter/ bowel
stenosis- No need of surgery
• 9 out of 10 will not progress
Operate, ONLY when-
1. Occlusive disease (ureter/ bowel)
2. Wishing natural conception, declining IVF
Dunselman et al., 2014; Berlanda et al., 2016; ETIC, 2018
Endometriosis Treatment
Italian Club, 2019
• Routine laparoscopy should
NOT be done in women with
infertility without pelvic pain
(Quality of evidence- High)
• Consider surgery for
superficial endometriosis
ONLY in women
1. Having moderate-severe pain
2. Seeking natural conception,
declining ART
Canadian Fertility and
Andrology Society, 2019
• In the absence of evidence for
tubal or other pelvic pathology,
laparoscopy is NOT
warranted in unexplained
infertility (Level II-2B).
ESHRE, 2023
• Routine diagnostic
laparoscopy is NOT
recommended for diagnosis of
unexplained infertility
ASRM, 2020
• ???
Case Scenario 6
• Mrs DH, 27 years, planning for pregnancy
• She underwent left ovarian cystectomy 6
years ago- H/P Endometrioma
• She is having severe dysmenorrhoea
• TVS- 5 cm chocolate cyst in right ovary
• AMH 0.8 ng/ml
58
Options
• Laparoscopy and decide
• Fertility preservation?
• In case of extensive
ovarian endometriosis,
clinicians should discuss
the pros and cons of
fertility preservation with
women with
endometriosis.
• The true benefit of
fertility preservation in
women with
endometriosis remains
unknown
ESHRE, 2022
59
AMH vs AFC-
and Endometrioma Surgery
Younis JS, Shapso N, Ben-Sira Y, Nelson SM, Izhaki I. Endometrioma surgery-a
systematic review and meta-analysis of the effect on antral follicle count and anti-
Müllerian hormone. Am J Obstet Gynecol. 2022 Jan;226(1):33-51.e7.
Endometriosis and ovarian reseve
• In endometriosis, with
and without a history of
ovarian surgery, ovarian
reserve markers were
worse (lower AMH and
higher FSH) compared to
women with male factors
Romanski PA, Brady PC, Farland LV, Thomas AM, Hornstein MD. The effect of
endometriosis on the antimüllerian hormone level in the infertile population. J
Assist Reprod Genet. 2019 Jun;36(6):1179-1184.
Endometrioma-related reduction in
ovarian reserve (ERROR)
Kasapoglu I, Ata B, Uyaniklar O, Seyhan A, Orhan A, Yildiz Oguz S, Uncu G.
Endometrioma-related reduction in ovarian reserve (ERROR): a prospective longitudinal
study. Fertil Steril. 2018 Jul 1;110(1):122-127.
Endometriosis- surgery or not
Yılmaz Hanege B, Güler Çekıç S, Ata B. Endometrioma and ovarian reserve: effects of
endometriomata per se and its surgical treatment on the ovarian reserve. Facts Views
Vis Obgyn. 2019 Jun;11(2):151-157.
Endometriosis and Subfertility - What to do?
One size does not fit for all
• Pain
• Age and Ovarian
reserve
• Previous surgery
• Male and tubal factor
• Patient’s wishes
For IVF
• Cost consideration
• Severity of pain
• Accessibility of the
follicles
• Hydrosalpinx
Take Home
• Take into account overall fertility picture, age,
symptoms, previous surgery
• During Medical therapy pregnancy is NOT possible
• Medical therapy (ovarian suppression) does NOT
improve chance of natural conception
• Surgery improves pain, clarifies diagnosis
• Surgery improves the chance of natural conception
• Immediately after surgery- Best period to conceive
• Surgery does NOT improve the success rate of IVF
Endometriosis and Subfertility - What to do?
1 de 63

Mais conteúdo relacionado

Mais procurados(20)

Doppler in gyneacology Dr. Muhammad Bin ZulfiqarDoppler in gyneacology Dr. Muhammad Bin Zulfiqar
Doppler in gyneacology Dr. Muhammad Bin Zulfiqar
Dr. Muhammad Bin Zulfiqar15.8K visualizações
A RARE CASE PRESENTATION OF OVARIAN ECTOPIC PREGNANCYA RARE CASE PRESENTATION OF OVARIAN ECTOPIC PREGNANCY
A RARE CASE PRESENTATION OF OVARIAN ECTOPIC PREGNANCY
Anu Manivannan1.9K visualizações
Radiotherapy in gynaecologyRadiotherapy in gynaecology
Radiotherapy in gynaecology
drmcbansal16.5K visualizações
SCREENING WHAT TESTS WHEN & WHAT NEXT?SCREENING WHAT TESTS WHEN & WHAT NEXT?
SCREENING WHAT TESTS WHEN & WHAT NEXT?
NARENDRA MALHOTRA2.2K visualizações
Recurrent pregnancy lossRecurrent pregnancy loss
Recurrent pregnancy loss
Priya Bhave.11K visualizações
CONTROVERSIES IN MANAGEMENT OF IUGRCONTROVERSIES IN MANAGEMENT OF IUGR
CONTROVERSIES IN MANAGEMENT OF IUGR
Aboubakr Elnashar3.5K visualizações
Epidemiology of Recurrent Pregnancy LossEpidemiology of Recurrent Pregnancy Loss
Epidemiology of Recurrent Pregnancy Loss
Kirtan Vyas664 visualizações
Pet in gynecological malignancies Pet in gynecological malignancies
Pet in gynecological malignancies
ikramdr012.5K visualizações
Role of hysteroscopy in Infertility, Dr Rajesh GajbhiyeRole of hysteroscopy in Infertility, Dr Rajesh Gajbhiye
Role of hysteroscopy in Infertility, Dr Rajesh Gajbhiye
Rajesh Gajbhiye6.4K visualizações
recurrent pregnancy lossrecurrent pregnancy loss
recurrent pregnancy loss
Kamel Ibrahim9K visualizações
Luteal Phase Insufficiency.pptxLuteal Phase Insufficiency.pptx
Luteal Phase Insufficiency.pptx
Raju Nair461 visualizações
NEW USES OF LASER  IN GYNECOLOGYNEW USES OF LASER  IN GYNECOLOGY
NEW USES OF LASER IN GYNECOLOGY
Aboubakr Elnashar5K visualizações
AtosibanAtosiban
Atosiban
Niranjan Chavan8.2K visualizações
Ovarian cancerOvarian cancer
Ovarian cancer
paviarun546 visualizações
Endometriosis and InfertilityEndometriosis and Infertility
Endometriosis and Infertility
Marwan Alhalabi2.1K visualizações

Similar a Endometriosis and Subfertility - What to do?(20)

Endometriosis in IVFEndometriosis in IVF
Endometriosis in IVF
Sujoy Dasgupta789 visualizações
Management of Endometrioma- Current UpdateManagement of Endometrioma- Current Update
Management of Endometrioma- Current Update
Sujoy Dasgupta235 visualizações
EndometriEndometri
Endometri
Lifecare Centre2.6K visualizações
Endometriosis and artEndometriosis and art
Endometriosis and art
NARENDRA MALHOTRA5.5K visualizações
SubfertilitySubfertility
Subfertility
Sujoy Dasgupta52 visualizações
Management of Infertility in EndometriosisManagement of Infertility in Endometriosis
Management of Infertility in Endometriosis
Sujoy Dasgupta1.2K visualizações
Estradiol Valerate in Fertility Care: New VistasEstradiol Valerate in Fertility Care: New Vistas
Estradiol Valerate in Fertility Care: New Vistas
Sujoy Dasgupta2.3K visualizações
Difficult Cases in IUIDifficult Cases in IUI
Difficult Cases in IUI
Sujoy Dasgupta337 visualizações
The Role of laparoscopy in the era of ARTThe Role of laparoscopy in the era of ART
The Role of laparoscopy in the era of ART
DrRokeyaBegum147 visualizações
Fertility management in ovarian endometrioma Fertility management in ovarian endometrioma
Fertility management in ovarian endometrioma
Sujoy Dasgupta694 visualizações
Fertility Preserving Hysteroscopic SurgeryFertility Preserving Hysteroscopic Surgery
Fertility Preserving Hysteroscopic Surgery
Sujoy Dasgupta1.1K visualizações

Mais de Sujoy Dasgupta(20)

Investigating Infertile MaleInvestigating Infertile Male
Investigating Infertile Male
Sujoy Dasgupta51 visualizações
Male Infertility- How Gynaecologists can manage?Male Infertility- How Gynaecologists can manage?
Male Infertility- How Gynaecologists can manage?
Sujoy Dasgupta99 visualizações
Troubleshooting in Male Subfertility Troubleshooting in Male Subfertility
Troubleshooting in Male Subfertility
Sujoy Dasgupta170 visualizações
ESHRE Guideline on Recurrent Pregnancy Loss (RPL)ESHRE Guideline on Recurrent Pregnancy Loss (RPL)
ESHRE Guideline on Recurrent Pregnancy Loss (RPL)
Sujoy Dasgupta746 visualizações
Abnormal Semen- What next?Abnormal Semen- What next?
Abnormal Semen- What next?
Sujoy Dasgupta198 visualizações
Low AMH- Is it linked to Infertility?Low AMH- Is it linked to Infertility?
Low AMH- Is it linked to Infertility?
Sujoy Dasgupta309 visualizações
Case Scenarios in ARTCase Scenarios in ART
Case Scenarios in ART
Sujoy Dasgupta86 visualizações
Day3 versus Day5 Embryo TransferDay3 versus Day5 Embryo Transfer
Day3 versus Day5 Embryo Transfer
Sujoy Dasgupta302 visualizações
Male Infertility- AntioxidantsMale Infertility- Antioxidants
Male Infertility- Antioxidants
Sujoy Dasgupta1.1K visualizações
Endometriosis and InfertilityEndometriosis and Infertility
Endometriosis and Infertility
Sujoy Dasgupta1.8K visualizações
Rational Investigations in Male InfertilityRational Investigations in Male Infertility
Rational Investigations in Male Infertility
Sujoy Dasgupta236 visualizações
Case Studies on Male Factor InfertilityCase Studies on Male Factor Infertility
Case Studies on Male Factor Infertility
Sujoy Dasgupta1.1K visualizações
Male Infertility What Gynaecologists should doMale Infertility What Gynaecologists should do
Male Infertility What Gynaecologists should do
Sujoy Dasgupta178 visualizações

Último

Classical conditioning theoryClassical conditioning theory
Classical conditioning theoryKavitha R
12 visualizações18 slides
Depression PPT templateDepression PPT template
Depression PPT templateEmanMegahed6
18 visualizações36 slides
Anorectal malformation.pptxAnorectal malformation.pptx
Anorectal malformation.pptxDrArjunPawar
177 visualizações93 slides
Melanie SquireMelanie Squire
Melanie SquireMelanie Squire
18 visualizações1 slide

Último(20)

JANUARY 2013-Classical Prescribing.pdfJANUARY 2013-Classical Prescribing.pdf
JANUARY 2013-Classical Prescribing.pdf
Allen College of Homoeopathy USA17 visualizações
Basic Life support (BLS) workshop presentation.Basic Life support (BLS) workshop presentation.
Basic Life support (BLS) workshop presentation.
Dr Sanket Nandekar24 visualizações
Classical conditioning theoryClassical conditioning theory
Classical conditioning theory
Kavitha R12 visualizações
Depression PPT templateDepression PPT template
Depression PPT template
EmanMegahed618 visualizações
Anorectal malformation.pptxAnorectal malformation.pptx
Anorectal malformation.pptx
DrArjunPawar177 visualizações
Melanie SquireMelanie Squire
Melanie Squire
Melanie Squire18 visualizações
Top 10 Pharma Companies in Mumbai | MedibyteTop 10 Pharma Companies in Mumbai | Medibyte
Top 10 Pharma Companies in Mumbai | Medibyte
Medibyte Pharma14 visualizações
HYDROCOLLATOR PACK by Dr. Aneri.pptxHYDROCOLLATOR PACK by Dr. Aneri.pptx
HYDROCOLLATOR PACK by Dr. Aneri.pptx
AneriPatwari106 visualizações
The AI apocalypse has been canceledThe AI apocalypse has been canceled
The AI apocalypse has been canceled
Tina Purnat114 visualizações
Pediatric IntussusceptionPediatric Intussusception
Pediatric Intussusception
DrArjunPawar54 visualizações
Virtual Healing: Transforming Healthcare Worker Wellness Through VRVirtual Healing: Transforming Healthcare Worker Wellness Through VR
Virtual Healing: Transforming Healthcare Worker Wellness Through VR
Badalona Serveis Assistencials13 visualizações
Relationships Between Service Providers and FamiliesRelationships Between Service Providers and Families
Relationships Between Service Providers and Families
Olaf Kraus de Camargo83 visualizações
LMLR 2023 Back and Joint Pain at 50LMLR 2023 Back and Joint Pain at 50
LMLR 2023 Back and Joint Pain at 50
Allan Corpuz314 visualizações
Case Study_ AI in the Life Sciences Industry.pptxCase Study_ AI in the Life Sciences Industry.pptx
Case Study_ AI in the Life Sciences Industry.pptx
Emily Kunka, MS, CCRP26 visualizações
 Fastest Growing Pharmaceutical Companies in India Fastest Growing Pharmaceutical Companies in India
Fastest Growing Pharmaceutical Companies in India
Unimarck Pharma India Ltd.36 visualizações
Scalp Cooling 101Scalp Cooling 101
Scalp Cooling 101
bkling44 visualizações
Anaemia,jaundice.pptxAnaemia,jaundice.pptx
Anaemia,jaundice.pptx
Reena Gollapalli14 visualizações
ROSE CASE CARDIAC  ARRHYTHMIA SBRTROSE CASE CARDIAC  ARRHYTHMIA SBRT
ROSE CASE CARDIAC ARRHYTHMIA SBRT
Kanhu Charan32 visualizações

Endometriosis and Subfertility - What to do?

  • 1. Dr Sujoy Dasgupta MBBS (Gold Medalist, Hons) MS (OBGY- Gold Medalist) DNB (New Delhi) MRCOG (London) Advanced ART Course for Clinicians (NUHS, Singapore) M Sc, Sexual and Reproductive Medicine (South Wales, UK) Clinical Director, Genome Fertility Centre, Kolkata Managing Committee Member, BOGS, 2023-24 Executive Committee Member, ISAR Bengal, 2022-24 Clinical Examiner, MRCOG Part 3 Examination Winner, Prof Geoffrey Chamberlain Award, RCOG World Congress, London, 2019 Endometriosis and subfertility….. what to do?
  • 2. • A chronic, estrogen- dependent, inflammatory, painful disorder in which endometrial tissue grows outside the uterus. • Known for recurrence • No single treatment is ideal for all patients, management chosen should be directed to individual needs of each patient • Combination therapy may be ideal • Couple’s problem • About 1/3rd of women with endometriosis also suffer from subfertility. • Endometriosis does not equal infertility. It just implies that some women may have a harder time becoming pregnant. • Once the endometriosis is treated then women often conceive naturally without any ART Endometriosis Subfertility
  • 3. Endometriosis and subfertility • Dysparaeunia • Distorted Pelvic Anatomy • Altered Peritoneal Function • Abnormal Uterotubal Transport • Hormonal and Ovulatory Abnormalities. • Impaired Implantation • Oocyte and Embryo Quality
  • 5. Endometriosis-subfertility: Basic principles of management • Medical management is not possible • Medical management does NOT improve the chance of conception • Laparoscopy confirms diagnosis and the severity • Laparoscopy improves pain • Laparoscopy improves chance of natural conception • Laparoscopy does NOT improve the success of IVF
  • 6. Case Scenario 1 • Mrs AC, 33 yr, trying for pregnancy for 2 years • c/o severe and progressively increasing dysmenorrhoea and dysparaeunia • TVS-
  • 7. Line of management? • Laparoscopy • Fertility preservation then consider laparoscopy • IVF only • Hormonal therapy for 3 months, then reevaluate
  • 8. Factors to decide the mode of treatment? Mrs AC Ovarian reserve- Age, AMH, AFC Age 33, AMH- 2.5 ng/ml, AFC- 8+10 Semen parameters Normozoospermia Tubal patency Tubes not yet checked Severity of symptoms Severe pain not responded to NSAID Past surgery No previous surgery Previous fertility treatment Received 6 cycles of letrozole for OI Patient’s wishes Relief of pain and wants to conceive
  • 9. Medical therapy Hormonal therapies • Clinicians should NOT prescribe ovarian suppression treatment to improve fertility • Most of the hormone therapies will prevent pregnancy • Ovarian suppression does NOT improve subsequent ovarian response (ESHRE, 2022) Analgesics • NSAIDs should be avoided around the time of ovulation
  • 10. Surgery for Endometriosis-Subfertility rASRM stage I/II Improves the rate of ongoing pregnancy. Both ablation and excision (CO2 laser vaporization > monopolar electrocoagulation) Endometrioma May increase their chance of natural pregnancy Cystectomy >> Drainage/coagulation Deep endometriosis  For infertility, severe pain, bowel stenosis radical excision combined with bowel segmental resection and anastomosis →improves spontaneous pregnancy rate • Operative lap > diagnostic lap • Still controversial if cumulative pregnancy rate is more after surgery but time to achieve pregnancy was significantly shorter • No compelling data from comparative studies exist (RCOG, 2017; NICE, 2017; ESHRE, 2022)
  • 11. Surgery for Endometriosis-Subfertility rASRM stage I/II Improves the rate of ongoing pregnancy. Both ablation and excision (CO2 laser vaporization > monopolar electrocoagulation) Endometrioma May increase their chance of natural pregnancy Cystectomy >> Drainage/coagulation Deep endometriosis  For infertility, severe pain, bowel stenosis radical excision combined with bowel segmental resection and anastomosis →improves spontaneous pregnancy rate • Operative lap > diagnostic lap • Still controversial if cumulative pregnancy rate is more after surgery but time to achieve pregnancy was significantly shorter • No compelling data from comparative studies exist (RCOG, 2017; NICE, 2017; ESHRE, 2022)
  • 12. Surgery for Endometriosis-Subfertility rASRM stage I/II Improves the rate of ongoing pregnancy. Both ablation and excision (CO2 laser vaporization > monopolar electrocoagulation) Endometrioma May increase their chance of natural pregnancy Cystectomy >> Drainage/coagulation Deep endometriosis  For infertility, severe pain, bowel stenosis radical excision combined with bowel segmental resection and anastomosis →improves spontaneous pregnancy rate • Operative lap > diagnostic lap • Still controversial if cumulative pregnancy rate is more after surgery but time to achieve pregnancy was significantly shorter • No compelling data from comparative studies exist (RCOG, 2017; NICE, 2017; ESHRE, 2022)
  • 13. 1. 3-10% chances of damaging the surrounding organs- bladder, bowel, ureter, nerves 2. Possible decline in ovarian reserve 3. Risk of oophorectomy 4. Complete excision of endometriotic tissue not possible. 5. May NOT reverse the inflammatory and biomolecular changes shown to influence fertilisation and implantation. 6. Needs skill Vercellini et al., 2009; Lebovic, 2016
  • 14. Mrs AC underwent laparoscopy • Right Ovarian 5 cm chocolate cyst removed • Severe adhesion in POD- complete adhesiolysis was done • Dye test B/L positive
  • 15. After laparoscopy- Attempt of natural conception or IVF? • Women should be counselled of their chances of becoming pregnant after surgery. • To identify patients that may benefit from ART after surgery, the Endometriosis Fertility Index (EFI) should be used as it is validated, reproducible and cost-effective. • The results of other fertility investigations such as their partner’s sperm analysis should be taken into account (ESHRE, 2022)
  • 17. Adamson and Pasta. Fertil Steril. 2010
  • 18. What should be the post-operative treatment plan? • Counselling • Ovarian suppression after surgery?  Chance of recurrence  After surgery- conception chance is high  Women seeking pregnancy should NOT be prescribed postoperative hormone suppression with the sole purpose to enhance future pregnancy rates (ESHRE, 2022)
  • 19. Mrs AC is now pain-free • Visited 4 doctors over the period of next 2 years. • Received different brands of letrozole for ovulation induction- total 12 cycles • She wants to do IUI
  • 20. ESHRE, 2022 rASRM stage I/II endometriosis •May perform IUI with ovarian stimulation, instead of expectant management or IUI alone •IUI+OS increases pregnancy rates. (better than expectant management or IUI alone) rASRM stage III/IV endometriosis •The value of IUI in women with tubal patency is uncertain •IUI +OS could be considered Can IUI be done in endometriosis?
  • 21. ESHRE, 2022 rASRM stage I/II endometriosis •May perform IUI with ovarian stimulation, instead of expectant management or IUI alone •IUI+OS increases pregnancy rates. (better than expectant management or IUI alone) rASRM stage III/IV endometriosis •The value of IUI in women with tubal patency is uncertain •IUI +OS could be considered Can IUI be done in endometriosis?
  • 22. Hughes, 1997 Meta-analysis- IUI success is halved in stage I/II endometriosis Gandhi et al., 2014 No difference between expectant management and IUI Dmowski et al., 2002 First-cycle chance of pregnancy with IVF is significantly higher than the cumulative pregnancy rate after 6 IUI cycles Van der Houwen et al., 2014; D’Hooghe et al., 2006 The risk of endometriosis recurrence appears to be increased by IUI (more than IVF) IVF, but not IUI, can be expected to overcome the detrimental effects of a pelvic inflammatory milieu. Limitations of IUI in endometriosis
  • 24. Case Scenario 2 • Mrs FR, 32 yr, has been trying for pregnancy for last 2 years. AMH, AFC, HSG all normal. • Husband is having azoospermia. Donor sperm is no acceptable. • B/L endometrioma (6 cm in right side, 4 cm left side) • Minimum dysmenorrhoea 25
  • 25. Options for Mrs FR 1. TESA-ICSI directly? 2. Laparoscopy before IVF-ICSI?  Severity of pain  Scan finding- 1. Cyst location 2. AFC 3. Accessibility of the follicles 4. Hydrosalpinx
  • 26. Surgery prior to IVF • Progressive decline in ovarian reserve • Higher gonadotrophin consumption • Lower number of oocyte retrieved Raffi et al., 2012; Somigliana et al., 2012; Sugita et al., 2013; Hamdan et al., 2015; Polyzos and Sunkara, 2015; Brink Laursen et al., 2017; Tao et al., 2017; Nickkho-Amiry et al., 2018
  • 27. Operative Lap does NOT improve IVF outcome In infertile women with endometrioma > 3 cm only consider cystectomy prior to ART to improve 1. endometriosis-associated pain or 2. the accessibility of follicles (ESHRE, 2022) Concern about endometrioma puncture during OPU? • In women with endometrioma, clinicians may use antibiotic prophylaxis at the time of oocyte retrieval, although the risk of ovarian abscess following follicle aspiration is low (0-1.9%) (ESHRE, 2022, RCOG 2017)
  • 28. Complications during and after OPU • Technical difficulties during oocyte retrieval is low, • No data to suggest that surgery will prevent adhesion reformation and facilitate oocyte retrieval effectively. • Risks of infection from an endometrioma (0–1.9%) • Follicular fluid contamination (2.8–6.1%) • Progression of pelvic endometriosis??? • Women with endometriosis can be reassured regarding the safety of ART since the recurrence rates are not increased compared to those women not undergoing ART. ESHRE, 2022; Koch et al., 2012; RCOG, 2017
  • 29. Ultrasound-guided Aspiration • Transvaginal USG-guided drainage without surgery does not seem to be effective. • a high recurrence rate • To decrease recurrence rate, aspiration is combined with in situ injection of tetracycline/ethanol/methotrexate • Disadvantages:  Complications: infection, abscess formation, and pain  inability to rule out any malignancy  risk of pelvic adhesion 31
  • 30. RCOG Scientific Impact Paper (2017) Directly ART • Asymptomatic women, • women of advanced reproductive age, • those with reduced ovarian reserve, • B/L endometriomas, • a history of prior ovarian surgery Surgery before IVF • Highly symptomatic women, • with an intact ovarian reserve, • unilateral and large cysts, • cysts with suspicious radiological and clinical features (The lifetime probability of Ca ovary 1-2%) 32
  • 31. IVF protocol for Endometriosis • Any specific IVF stimulation protocol? • Pretreatment COC/ Progesterone? • No specific protocol can be recommended. • Both GnRH antagonist and agonist protocols can be offered based on patients’ and physicians’ preferences as no difference in pregnancy or live birth rate has been demonstrated • Insufficient evidence to recommend prolonged administration of the COC/progestogens as a pre-treatment to ART to increase live birth rates (ESHRE, 2022)
  • 32. Down regulation with GnRH agonist depot? • The administration of GnRH agonists for a period of 3-6 months prior to IVF or ICSI in women with endometriosis increases the odds of clinical pregnancy by 4-fold.
  • 33. Georgiou EX, Melo P, Baker PE, Sallam HN, Arici A, Garcia‐Velasco JA, Abou‐Setta AM, Becker C, Granne IE. Long‐term GnRH agonist therapy before in vitro fertilisation (IVF) for improving fertility outcomes in women with endometriosis. Cochrane Database of Systematic Reviews 2019, Issue 11. Art. No.: CD013240. DOI: 10.1002/14651858.CD013240.pub2 • In light of the paucity and very low quality of existing data, particularly for the primary outcomes examined, further high‐quality trials are required to definitively determine the impact of long‐term GnRH agonist therapy on IVF/ICSI outcomes, not only compared to no pretreatment, but also compared to other proposed alternatives to endometriosis management
  • 34. Paradigm Shift? ESHRE, 2013 ESHRE, 2022 • Clinicians can prescribe GnRH agonists for a period of 3 to 6 months prior to treatment with ART to improve clinical pregnancy rates in infertile women with endometriosis • The extended administration of GnRH agonist prior to ART treatment to improve live birth rate in infertile women with endometriosis (ultralong protocol) is no longer recommended due to unclear benefits.
  • 35. Muller V, Kogan I, Yarmolinskaya M, Niauri D, Gzgzyan A, Aylamazyan E. (2017). Dienogest treatment after ovarian endometrioma removal in infertile women prior to IVF, Gynecological Endocrinology, 33:sup1, 18-21,
  • 36. Tamura, H., Yoshida, H., Kikuchi, H. et al. The clinical outcome of Dienogest treatment followed by in vitro fertilization and embryo transfer in infertile women with endometriosis. J Ovarian Res 12, 123 (2019). • No significant difference in the implantation and miscarriage rates between the groups • The cumulative pregnancy rate and live birth rate were lower in the DNG group than in the control group.
  • 37. Case Scenario 3 • Mrs PC, 34 yr, trying for pregnancy for 1 year. • All investigations (Semen, AMH, HSG) normal. • 2 cm endometrioma in left ovary. • No pain.
  • 38. Conservative management for spontaneous conception Encourage to try natural conception before seeking fertility treatment- 1. Young women, 2. regular menstrual cycles and 3. an incidental finding of an ovarian endometrioma 4. without suspicion of malignancy •43% spontaneous pregnancy rate during the 6-month follow up period •Similar ovulation rates in the affected ovary to the healthy ovary Benaglia et al., 2009; Leone Roberti Maggiore et al., 2015; RCOG, 2017 40
  • 40. Case Scenario 4 • Mrs MS, 28 yr, trying for pregnancy for 3 years. She had severe dysmenorrhoea, dyschezia and dysuria. • There was 5 cm unilateral endometrioma and MRI scan suggested the possibility of rectosigmoid endometriosis. • AMH 2.3 ng/ml, tubes not checked, husband’s semen normal. • She wanted to defer surgery for 4 months because of professional commitments
  • 41. Preoperative hormonal therapies NICE, 2017 •Consider GnRH agonist x 3 cycles before surgery for deep infiltrating endometriosis ESHRE, 2022 •In clinical practice, surgeons prescribe preoperative medical treatment with GnRH agonists as this can facilitate surgery due to reduced inflammation, vascularisation of endometriosis lesions and adhesions •No controlled studies supporting this •Should be offered before surgery to women with painful symptoms in the waiting period before the surgery can be performed, with the purpose of reducing pain before, not after, surgery.
  • 42. Mrs MS underwent Laparoscopy • Grade IV endometriosis • Tubes and ovaries difficult to identify • Tubal patency- Right- slow spill, Left- no spill • Adhesiolysis could not be done 44
  • 43. Next step • GnRH Agonist/ Dineogest post-op • IVF • Re-operation by expert 45
  • 44. Complete excision group vs incomplete excision • significantly higher complication rate (9.1% VS 0%, P<0.001) • significant decrease in pain (VAS score 5.6±3.9 VS 2.9±3.3, P=0.001) • significantly lower postoperative recurrence rate (3.9% VS 35.3%, P=0.000) • similar pregnancy rate Complete excision vs incomplete excision + post- operative GnRH agonist • similar pain score (5.6±3.9 VS 4.5±3.2, P=0.272). • significantly lower recurrence rate (3.9% VS 29.4%, P=0.000).
  • 45. How does endometriosis affect oocytes and embryos? • Ooplasm- “dark cytoplasm," "and "diffused cytoplasmic granularity.“ (Rienzi et al., 2011). • Oocytes with degenerative signs (Ayse et al., 2014). • Altered oocyte morphology, abnormal mitochondrial content (Sanchez et al., 2017). • Altered follicular fluid molecules (VEGF, IL-6) (Garrido et al., 2000).
  • 46. Does endometriosis affect IVF success? • Systematic review- stage I and II endometriosis, the pregnancy rate was similar to that in tubal infertility, although in stage III and IV endometriosis, the pregnancy rate was significantly poor (Barnhart, et al., 2012). • ESHRE database- No difference in IVF outcome between endometriosis and other fertility issues (Dunselman et al., 2014). • Recent Meta-analysis- Endometriosis does NOT affect embryo quality or IVF outcome (Dongye et al., 2021. Qu et al., 2022).
  • 47. Ms MS had IVF-Failure Role of laparoscopy? • Normal HSG, repeated IVF failure- 57% cases can have endometriosis- surgical treatment improves outcome (Yu et al., 2019) • In symptomatic women with severe endometriosis- surgery improves IVF outcome (Soriano et al., 2016) • Need to do 40 laparoscopy to achieve a pregnancy (ASRM, 2012) • Down-regulation with GnRH agonist and letrozole may be useful in RIF patients without surgically proved endometriosis (Moustafa and Young, 2020)
  • 48. Case Scenario 5 • Mrs JK, 37 years trying for pregnancy for 4 years • Tried multiple cycles of OI with letrozole and CC • HSG, AMH, Semen all normal • No dysmenorrhoea • “Unexplained Subfertility” • Role of laparoscopy to diagnose endometriosis and treatment? 50
  • 49. Unexplained Infertility • Reflects an incomplete fertility evaluation • 20-40% cases of unexplained infertility may be because of undiagnosed endometriosis Hurt, 2003; Fadhlaoui et al., 2014
  • 51. Recent Studies on Endometriosis and Unexplained Infertility  RMeta-Analysis • Success rate of IVF - ∼25% (NNT- 4) European IVF-Monitoring Consortium (EIM) for ESHRE, 2016 Jacobson et al., 2010 Duffy et al., 2014 OR for ongoing pregnancy (95% CI) 1.64 (1.05– 2.57) 1.94 (1.20–3.16) The number of infertile women that should undergo destruction of superficial peritoneal endometriosis 12 8 The prevalence of grade I/ II endometriosis among women with unexplained infertility ≤50% NNT 24 16
  • 52. Laparoscopy to diagnose asymptomatic DIE? • Uncommon to be asymptomatic • Uncomplicated- If no symptoms of ureter/ bowel stenosis- No need of surgery • 9 out of 10 will not progress Operate, ONLY when- 1. Occlusive disease (ureter/ bowel) 2. Wishing natural conception, declining IVF Dunselman et al., 2014; Berlanda et al., 2016; ETIC, 2018
  • 53. Endometriosis Treatment Italian Club, 2019 • Routine laparoscopy should NOT be done in women with infertility without pelvic pain (Quality of evidence- High) • Consider surgery for superficial endometriosis ONLY in women 1. Having moderate-severe pain 2. Seeking natural conception, declining ART Canadian Fertility and Andrology Society, 2019 • In the absence of evidence for tubal or other pelvic pathology, laparoscopy is NOT warranted in unexplained infertility (Level II-2B). ESHRE, 2023 • Routine diagnostic laparoscopy is NOT recommended for diagnosis of unexplained infertility ASRM, 2020 • ???
  • 54. Case Scenario 6 • Mrs DH, 27 years, planning for pregnancy • She underwent left ovarian cystectomy 6 years ago- H/P Endometrioma • She is having severe dysmenorrhoea • TVS- 5 cm chocolate cyst in right ovary • AMH 0.8 ng/ml 58
  • 55. Options • Laparoscopy and decide • Fertility preservation? • In case of extensive ovarian endometriosis, clinicians should discuss the pros and cons of fertility preservation with women with endometriosis. • The true benefit of fertility preservation in women with endometriosis remains unknown ESHRE, 2022 59
  • 56. AMH vs AFC- and Endometrioma Surgery Younis JS, Shapso N, Ben-Sira Y, Nelson SM, Izhaki I. Endometrioma surgery-a systematic review and meta-analysis of the effect on antral follicle count and anti- Müllerian hormone. Am J Obstet Gynecol. 2022 Jan;226(1):33-51.e7.
  • 57. Endometriosis and ovarian reseve • In endometriosis, with and without a history of ovarian surgery, ovarian reserve markers were worse (lower AMH and higher FSH) compared to women with male factors Romanski PA, Brady PC, Farland LV, Thomas AM, Hornstein MD. The effect of endometriosis on the antimüllerian hormone level in the infertile population. J Assist Reprod Genet. 2019 Jun;36(6):1179-1184.
  • 58. Endometrioma-related reduction in ovarian reserve (ERROR) Kasapoglu I, Ata B, Uyaniklar O, Seyhan A, Orhan A, Yildiz Oguz S, Uncu G. Endometrioma-related reduction in ovarian reserve (ERROR): a prospective longitudinal study. Fertil Steril. 2018 Jul 1;110(1):122-127.
  • 59. Endometriosis- surgery or not Yılmaz Hanege B, Güler Çekıç S, Ata B. Endometrioma and ovarian reserve: effects of endometriomata per se and its surgical treatment on the ovarian reserve. Facts Views Vis Obgyn. 2019 Jun;11(2):151-157.
  • 61. One size does not fit for all • Pain • Age and Ovarian reserve • Previous surgery • Male and tubal factor • Patient’s wishes For IVF • Cost consideration • Severity of pain • Accessibility of the follicles • Hydrosalpinx
  • 62. Take Home • Take into account overall fertility picture, age, symptoms, previous surgery • During Medical therapy pregnancy is NOT possible • Medical therapy (ovarian suppression) does NOT improve chance of natural conception • Surgery improves pain, clarifies diagnosis • Surgery improves the chance of natural conception • Immediately after surgery- Best period to conceive • Surgery does NOT improve the success rate of IVF

Notas do Editor

  1. The specific question of GnRH agonist pre-treatment has been addressed in an older Cochrane review (Sallam, et al., 2006) that – based on three included studies in a total of 228 patients – concluded that prolonged downregulation for 3–6 months with a GnRH agonist in women with endometriosis increases the odds of clinical pregnancy by more than 4-fold. In contrast, the updated version of this Cochrane review (Georgiou, et al., 2019), including 8 parallel-design RCTs involving a total of 640 participants, concluded that the effect of GnRH agonist pre-treatment (for at least 3 months) was very uncertain, both on live birth rate as primary outcome, as well as on secondary outcomes (clinical pregnancy rate, multiple pregnancy rate, miscarriage rate, mean number of oocytes and mean number of embryos). All studies included in this review have compared long-term GnRH agonist versus no pre-treatment. The authors acknowledged the very low quality of data, particularly for reporting live birth rate. Compared to the previous version of the review, the outcome of live birth now includes only one new unpublished trial (NCT01581359) and excludes a previously included RCT (Dicker, et al., 1992) as this paper does not truly report on live birth as per the definition of the international glossary on infertility and fertility care (Georgiou, et al., 2019). For the outcome of clinical pregnancy rate (CPR), the review includes three new RCTs, leading to the results being closer to the line of no effect.
  2. hypoestrogenic (GnRH agonist), hyperandrogenic (danazol, gestrinone) or hyperprogestogenic (oral contraceptives, medroxyprogesterone acetate) state that suppresses endometrial cell proliferation.